Results
20,315 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 |  Gilbert Ray Cisneros, Jr.DSelf |  STRLSTERLING INFRASTRUCTURE, INC.Partial sale | SELL | $1,001 – $15K | Jul 2, 2026 traded Jun 30, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Gilbert Ray Cisneros, Jr.DSelf | STRLSTERLING INFRASTRUCTURE, INC. Partial sale | SELL | $1,001 – $15K | Jul 2, 2026 traded Jun 30, 2026 | |
Gilbert Ray Cisneros, Jr.DSelf |
 COINCoinbase Global, Inc.Sale |
| SELL |
| $1,001 – $15K |
| Jul 2, 2026 traded Jun 16, 2026 |
| 16 | McCulloch KevinSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $723K 90.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 16 | Gilbert Ray Cisneros, Jr.DSelf |  TTDTrade Desk, Inc.Sale | SELL | $1,001 – $15K | Jul 2, 2026 traded Jun 16, 2026 |
| 15 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $36K 1,200 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 13 | Gilbert Ray Cisneros, Jr.DSelf |  WRBBERKLEY W R CORPPartial sale | SELL | $1,001 – $15K | Jul 2, 2026 traded Jun 5, 2026 |
| 13 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $64K 741 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 13 | Ribeiro RamiroChief Medical Officer |  EYPTEyePoint, Inc.Open-market sale · 10b5-1 plan | SELL | $37K 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Ribeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $208K 12.8K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $290K 3,500 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $327K 3,900 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $35K 1,305 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 47 | Bhalla Narinder PalChief Medical Officer |  LXEOLexeo Therapeutics, Inc.Open-market sale | SELL | $99K 22.3K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 39 | Townsend Richard NolanDirector, Chief Executive Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $116K 25.9K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 39 | Linz Terrence JamesPresident, Wholesale Brands |  LZBLA-Z-BOY INCOpen-market sale | SELL | $101K 2,500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 39 | Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $72K 21.2K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 36 | Zafrani EdenCHRO |  NYAXNayax Ltd.Open-market sale | SELL | $32K 500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 36 | Tamayo Louis EdwardChief Financial Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $21K 4,641 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 32 | Berho Carranza Lorenzo DominiqueChief Executive Officer | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $171K 50.0K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 32 | Berho Carranza Lorenzo DominiqueChief Executive Officer | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $171K 50.0K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 32 | Otero Jose ManuelChief Operating Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $21K 4,666 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 32 | Berho Corona Lorenzo ManuelDirector | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $171K 50.0K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 32 | Berho Carranza DiegoChief Portfolio Officer | VTMXVesta Real Estate Corporation, S.A.B. de C.V. Open-market sale | SELL | $12K 3,500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 28 |  Max L. MillerRSelf | Cliffwater Corporate Lending Fund (Ticker: CCLFX) Partial sale | SELL | $15K – $50K | Jul 1, 2026 traded May 29, 2026 |
| 28 | Max L. MillerRSelf | Cliffwater Corporate Lending Fund (Ticker: CCLFX) Partial sale | SELL | $15K – $50K | Jul 1, 2026 traded May 29, 2026 |
| 22 | Blumenthal Neil HarrisDirector, Co-Chief Executive Officer |  WRBYWarby Parker Inc.Open-market sale · 10b5-1 plan | SELL | $1.09M 36.3K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 21 | Paul Josh D.Chief Accounting Officer |  PANWPalo Alto Networks IncOpen-market sale · 10b5-1 plan | SELL | $311K 900 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 21 | Barone FrancescaChief Scientific Officer |  CADLCandel Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $236K 23.4K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 20 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Open-market sale | SELL | $552K 26.6K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 19 | ten Bosch John RoderickSVP of Laboratory Operations |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $170K 1,416 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 17 | Tyagarajan SeshuChief Technology Officer | CADLCandel Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $70K 7,000 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 14 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 7,500 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 1 | McNamara PeterChief Scientific Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $6,020 172 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS |  BETABETA Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $246K 15.0K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 1 | Clark KyleDirector, SEE REMARKS | BETABETA Technologies, Inc. Open-market sale · 10b5-1 plan | SELL | $249K 15.0K sh | Jul 1, 2026 traded Jun 30, 2026 |
| 1 | Bliss KellyPresident, U.S. Group Health |  TDOCTeladoc Health, Inc.Open-market sale · 10b5-1 plan | SELL | $23K 2,500 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 50 | Richmond Raphaell Z.VP, GC & Chief Compliance Off | LZBLA-Z-BOY INC Open-market sale | SELL | $545K 13.7K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 44 | Hunt Jolie A.Director |  NYSEKRCKILROY REALTY CORPOpen-market sale | SELL | $597K 15.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 41 | Warren EricChief Commercial Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $2.70M 104.1K sh | Jun 30, 2026 traded Jun 26, 2026 |